Allison Bayer

Allison Bayer,

Associate Professor

Department: MD-PATHOLOGY-GENERAL
Business Phone: (352) 273-9703
Business Email: allisonbayer@ufl.edu

On This Page

Teaching Profile

Courses Taught

  1. GMS6140 – Principles of Immunology

    College of Medicine

  2. GMS6383 – Current Topics in Immunotherapy

    College of Medicine

  3. VME6505 – Autoimmunity

    College of Veterinary Medicine

Publications

Academic Articles

  1. Insulin-like Growth Factor-1 Synergizes with IL-2 to Induce Homeostatic Proliferation of Regulatory T Cells

    Journal
    The Journal of Immunology.
    Volume/Issue
    211(7):1108-1122
    [DOI]
    10.4049/jimmunol.2200651.
    [PMID]
    37594278.
  2. Immunosuppressive PLGA TGF-β1 Microparticles Induce Polyclonal and Antigen-Specific Regulatory T Cells for Local Immunomodulation of Allogeneic Islet Transplants.

    Journal
    Frontiers in immunology.
    Volume/Issue
    12
    [DOI]
    10.3389/fimmu.2021.653088.
    [PMID]
    34122410.
  3. In vitro platform establishes antigen-specific CD8+ T cell cytotoxicity to encapsulated cells via indirect antigen recognition.

    Journal
    Biomaterials.
    Volume/Issue
    256
    [DOI]
    10.1016/j.biomaterials.2020.120182.
    [PMID]
    32599358.
  4. Correction to: In vivo imaging of type 1 diabetes immunopathology using eye-transplanted islets in NOD mice.

    Journal
    Diabetologia.
    Volume/Issue
    62(8)
    [DOI]
    10.1007/s00125-019-4922-1.
    [PMID]
    31190158.
  5. In vivo imaging of type 1 diabetes immunopathology using eye-transplanted islets in NOD mice.

    Journal
    Diabetologia.
    Volume/Issue
    62(7):1237-1250
    [DOI]
    10.1007/s00125-019-4879-0.
    [PMID]
    31087105.

Grants

  1. Restoration of immune regulation in type 1 diabetes through the synergistic action of insulin-like growth factor-1 and interleukin-2

    Active

    Role:
    Co-Project Director/Principal Investigator
    Funding:
    BREAKTHROUGH T1D – formerly JDRF Intl
  2. Combination therapy with Ladarixin and anti-CD3 for the prevention of Type 1 diabetes in NOD mice

    Active

    Role:
    Principal Investigator
    Funding:
    DOMPE PHARMACEUTICALS
  3. Conformal islet encapsulation for transplantation at vascularized sites to allow physiological insulin secretion

    Active

    Role:
    Principal Investigator
    Funding:
    UNIV OF MIAMI via NATL INST OF HLTH NIDDK
  4. GLUT1 Inhibition in type 1 diabetes

    Active

    Role:
    Principal Investigator
    Funding:
    CITY OF HOPE via BREAKTHROUGH T1D – formerly JDRF Intl
  5. Combinational immune therapies with antigen-specific Tregs for tolerance induction in islet transplantation

    Active

    Role:
    Principal Investigator
    Funding:
    BREAKTHROUGH T1D – formerly JDRF Intl
  6. Role of mTORC1 signaling in type 1 diabetes

    Active

    Role:
    Principal Investigator
    Funding:
    UNIV OF MIAMI via NATL INST OF HLTH NIDDK
  7. Use of dimethyl fumarate for targeting autoimmunity in type 1 diabetes

    Role:
    Principal Investigator
    Funding:
    UNIV OF MIAMI via NATL INST OF HLTH NIAID
  8. Engineering Immunomodulatory Nanoscale Coatings for Protecting Islet Transplants

    Active

    Role:
    Co-Project Director/Principal Investigator
    Funding:
    NATL INST OF HLTH NIDDK

Contact Details

Phones:
Business:
(352) 273-9703
Emails:
Addresses:
Business Mailing:
PO Box 100275
GAINESVILLE FL 32610
Business Street:
BMS J581
1275 Center Drive
GAINESVILLE FL 32610